Arnon Rosenthal
Net Worth
Last updated:
What is Arnon Rosenthal net worth?
The estimated net worth of Dr. Arnon Rosenthal is at least $26,279,310 as of 2 Dec 2024. He owns shares worth $5,365,138 as insider, has earned $18,650,092 from insider trading and has received compensation worth at least $2,264,080 in Alector, Inc..
What is the salary of Arnon Rosenthal?
Dr. Arnon Rosenthal salary is $566,020 per year as Co-Founder, Chief Executive Officer & Director in Alector, Inc..
How old is Arnon Rosenthal?
Dr. Arnon Rosenthal is 69 years old, born in 1956.
What stocks does Arnon Rosenthal currently own?
As insider, Dr. Arnon Rosenthal owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Alector, Inc. (ALEC) | Co-Founder, Chief Executive Officer & Director | 2,507,074 | $2.14 | $5,365,138 |
What does Alector, Inc. do?
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.
Arnon Rosenthal insider trading
Alector, Inc.
Dr. Arnon Rosenthal has made 19 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 52,172 units of ALEC stock worth $131,421 on 2 Dec 2024.
The largest trade he's ever made was exercising 100,000 units of ALEC stock on 20 Sep 2021. As of 2 Dec 2024 he still owns at least 2,507,074 units of ALEC stock.
Alector key executives
Alector, Inc. executives and other stock owners filed with the SEC:
- Dr. Arnon Rosenthal (69) Co-Founder, Chief Executive Officer & Director
- Dr. Robert Paul M.D., Ph.D. (57) Advisor
- Dr. Robert S. King (62) Chief Devel. Officer
- Dr. Tillman Ulf Gerngross Ph.D. (61) Co-Founder & Chairman
- Mr. Calvin Yu (49) Vice President of Fin.